title: [Role of urologists in the era of new treatment modalities for CRPC in Japan].
abstract: New medical treatment modalities for castration resistant prostate cancer(CRPC), including hormonal therapy and chemotherapy, will be approved in Japan. Here, we discuss the management of these new treatment strategies by urologists.
authors.affiliation: Dept. of Urology, Hamamatsu University School of Medicine.
authors.forename: Seiichiro
authors.initials: S
authors.lastname: Ozono
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D006801:Humans; D007564:Japan; D008297:Male; D010819:Physician's Role; D017410:Practice Guidelines as Topic; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents